Pharmacologically targeting inflammation and improving cerebrospinal fluid circulation improves outcome after subarachnoid haemorrhage

• Marietta Zille,
• Nikolaus Plesnila,
• Johannes Boltze

Affiliations

Marietta Zille

Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, UZA II, Althanstr. 14, Vienna 1090, Austria

Nikolaus Plesnila

Institute for Stroke and Dementia Research (ISD), Munich University Hospital, LMU Munich, Feodor-Lynen Str. 17, Munich 81377, Germany; Munich Cluster of Systems Neurology (Synergy), LMU Munich, Feodor-Lynen Str. 17, 81377 Munich, Germany

Johannes Boltze

School of Life Sciences, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, United Kingdom; Corresponding author.